ADMP Adamis Pharmaceuticals Corp

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.

$0.14
As of 10/05/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  149,983,265
Average volume:  1,260,717
Market cap:   $24,762,237
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -0.62
PB ratio:   1.48
PS ratio:   2.33
Return on equity:   -111.90%
Net income %:   -167.50%